Medical device licence · 90140 · Class 2
MAST ADATAB
No longer licensed: suspended: invalid quality-system certificate
Licence status Suspended: invalid quality-system certificate; first licensed November 20, 2012; ended July 29, 2019. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 90140
- Licence holder
- Mast Group LimitedBootle, MY, United Kingdom
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- November 20, 2012
- Ended
- July 29, 2019
- Devices covered
- 72
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- AMIKACIN ADATAB
- AMINOSIDINE ADATAB
- AMOXYCILLIN ADATAB
- AMPICILLIN ADATAB
- AMPICILLIN/SULBACTAM ADATAB
- AUGMENTIN ADATAB
- AZITHROMYCIN ADATAB
- AZLOCILLIN ADATAB
- AZTREONAM ADATAB
- CEFADROXIL ADATAB
- CEFEPIME ADATAB
- CEFIXIME ADATAB
- CEFMETAZOLE ADATAB
- CEFOTAXIME ADATAB
- CEFOTETAN ADATAB
- CEFOXITIN ADATAB
- CEFPIROME ADATAB
- CEFPODOXIME ADATAB
- CEFTAZIDIME ADATAB
- CEFTIBUTEN ADATAB
- CEFTRIAXONE ADATAB
- CEFUROXIME ADATAB
- CEPHALEXIN ADATAB
- CEPHALOTIN ADATAB
- CEPHAMANDOLE ADATAB
- CEPHRADINE ADATAB
- CHLORAMPHENICOL ADATAB
- CIPROFLOXACIN ADATAB
- CLARITHROMYCIN ADATAB
- CLINDAMYCIN ADATAB
- COLISTIN ADATAB
- COTRIMOXAZOLE ADATAB
- DOXYCYCLINE ADATAB
- ERTAPENEM ADATAB
- ERYTHROMYCIN ADATAB
- FOSFOMYCIN TROMETAMOL ADATAB
- FUSIDIC ACID ADATAB
- GATIFLOXACIN ADATAB
- GENTAMICIN ADATAB
- IMIPENEM ADATAB
- LEVOFLOXACIN ADATAB
- LINEZOLID ADATAB
- LORACARBEF ADATAB
- MECILLINAM ADATAB
- MEROPENEM ADATAB
- METHICILLIN ADATAB
- METRONIDAZOLE ADATAB
- MEZLOCILLIN ADATAB
- MOXIFLOXACIN ADATAB
- MUPIROCIN ADATAB
- NALIDIXIC ACID ADATAB
- NEOMYCIN ADATAB
- NETILMICIN ADATAB
- NITROFURANTOIN ADATAB
- NORFLOXACIN ADATAB
- NOVOBIOCIN ADATAB
- OFLOXACIN ADATAB
- OXACILLIN ADATAB
- PENICILLIN ADATAB
- PIPERACILLIN ADATAB
- PIPERACILLIN/TAZOBACTAM ADATAB
- RIFAMPICIN ADATAB
- SPECTINOMYCIN ADATAB
- STREPTOMYCIN ADATAB
- SULPHAMETHOXAZOLE ADATAB
- SYNERCID ADATAB
- TEICOPLANIN ADATAB
- TETRACYCLINE ADATAB
- TIMENTIN ADATAB
- TOBRAMYCIN ADATAB
- TRIMETHOPRIM ADATAB
- VANCOMYCIN ADATAB
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.